Related Experiment Video
Updated: Mar 22, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Screening for Depression and Anxiety in Epilepsy
Kirsten M Fiest1, Scott B Patten2, Nathalie Jetté3
1Department of Internal Medicine, Health Sciences Centre, College of Medicine, University of Manitoba, 820 Sherbrook Street, MS740B, Winnipeg, Manitoba R3A 1R9, Canada.
Abstract:
Depression and anxiety are common comorbidities of epilepsy and have far-reaching effects on patients, family, and the health care system. Although the burden of these conditions is high, a majority of cases are undetected and untreated. Screening tools can be a fast way to establish the presence of clinically relevant symptoms of depression and anxiety in epilepsy. Depression tools have been extensively studied in epilepsy, although no scale has been definitively established for use in this population. Anxiety has been understudied in epilepsy; few scales exist to measure anxiety and these scales have not been well validated.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

